Sensate, a London-based start-up and a subsidiary of Bioself, has raised $3.2 million in seed funding to develop its stress-reducing consumer system further. The investors in the round include What If Ventures, Unlock Venture Partners, Moai Capital, Dangerous Ventures, Geek Ventures, Share Ventures, and Incisive Ventures.

Sensate's product, also called Sensate, uses a unique patent-pending process to calm the fight-flight-freeze response and improve heart rate variability (HRV) enjoyably and engagingly. The device provides a simple and accessible solution to soothe stress instantly without requiring skill or effort.

The seed funding will be used by Sensate to enhance the product's features and expand its reach.

Sensate is already gaining popularity as a stress management solution and is poised for even wider adoption with the support of its investors. Visit us for more information: https://founderlodge.com/round/Sensate-raises-3200000-Seed-2023-03-17-Anna-Gudmundson-MTEwMzQ